Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Allergy & Immunology
COVID-19
Questions discussed in this category
Should we recommend the COVID-19 booster vaccine to patients who had a DVT or any other complications such as hemolytic anemia or thrombocytopenia from prior vaccine doses?
2 Answers available
Is there a role for antibody testing to confirm vaccine response for patients on rituximab after COVID-19 vaccination?
1 Answer available
Do you recommend COVID vaccination in patients with antiphospholipid antibody positivity or other prothrombotic states not on anti-coagulation?
1 Answer available
How are you timing the third dose of the COVID-19 mRNA vaccine in patients on rituximab?
1 Answer available
In which patients with autoimmune or inflammatory conditions are you recommending a 3rd dose of the mRNA COVID vaccine?
2 Answers available
How would you advise patients with known stable autoimmune thrombocytopenia regarding the Ad26.COV2.S (Johnson & Johnson/Janssen) vaccine?
1 Answer available
How do you advise patients who had autoimmune diseases "triggered" by COVID infections on getting COVID vaccination?
E.g., inflammatory polyarthritis or inflammatory myopathy with onset within 2 weeks of documented COVID infection
1 Answer available
10666
10024
10840
10610
10555
9779
9613
Papers discussed in this category
Lancet Rheumatol, 2021 Apr 06
Incident systemic rheumatic disease following COVID-19.
N Engl J Med, 2020 Nov 20
Covid-19-Associated Myopathy Caused by Type I Interferonopathy.
Blood,
Adenovirus-induced thrombocytopenia: the role of von Willebrand factor and P-selectin in mediating accelerated platelet clearance.
Arthritis Rheumatol, 2021 May 24
American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 1.
Semin Hematol,
Epidemiology and risk factors for venous thrombosis.
Thromb Res, 2021 Jun 25
Absence of hypercoagulability after nCoV-19 vaccination: An observational pilot study.
Related Topics in Allergy & Immunology
Breast Cancer
Hematologic Malignancies
Radiation Oncology
Pediatric Hematology/Oncology
Medical Oncology
Bone Marrow Transplant
Biologic Therapy/Immunobiology
Internal Medicine
Rheumatology
ALL